K-One MM

Introducing K-One MM Vitalis

K-One MM is a medication specifically designed to address vitamin K deficiency in the body. It plays a vital role in improving conditions caused by insufficient levels of vitamin K. Vitamin K is a crucial nutrient necessary for both blood clotting and bone metabolism. To ensure its safe and effective use, K-One MM should only be administered under the supervision of a healthcare professional and not self-administered. Regular intake is essential to derive maximum benefits. Alongside this medication, a comprehensive treatment program may involve dietary adjustments and the use of vitamin supplements. K-One MM is generally well-tolerated, with minimal to no side effects reported. However, in some cases, individuals may experience pain, redness, or swelling at the injection site. Prior to starting this medication, it is crucial to inform your doctor about any other medications you are taking to ensure your safety. Seeking advice from your doctor before incorporating additional vitamin supplements is also important.

Indications for K-One MM

• Vitamin K deficiency
• Over-anticoagulation
• Vitamin K deficiency bleeding

Administration of K-One MM

K-One MM can be taken with or without food.

Adult Dosage

Oral:

• Vitamin K deficiency due to drugs or malabsorption: Adult dosage is 10-40 mg daily.
• Over-anticoagulation: Adult dosage varies based on INR (International Normalized Ratio) and the severity of bleeding, with doses of up to 5 mg being used.

Intravenous:

• Over-anticoagulation: Adult dosage depends on INR and the degree of bleeding, ranging from 0.5-5 mg via slow intravenous injection.

Dosage for Children

Intramuscular:

• Prophylaxis of vitamin K deficiency bleeding in neonates: For neonates, a single dose of 0.5-1 mg is given via intramuscular injection. Alternatively, 2 mg may be administered orally, followed by a second dose of 2 mg after 4-7 days.

Parenteral:

• Vitamin K deficiency bleeding in neonates: For infants, an initial dose of 1 mg can be given via intravenous, intramuscular, or subcutaneous injection, with further doses administered if necessary.

Contraindications for K-One MM

Hypersensitivity to the medication.

Mode of Action of K-One MM

K-One MM, also known as phytomenadione, enhances the synthesis of clotting factors in the liver. It is a naturally occurring compound used to prevent and treat hemorrhages associated with vitamin K deficiency.

Precautions while using K-One MM

Caution should be exercised in the following situations:

• Increased risk of severe hemolytic anemia in neonates after large doses
• Severe hepatic impairment
• Pregnancy
• Premature neonates weighing less than 2.5 kg
• Lactation: Excretion in breast milk; use caution

Side Effects of K-One MM

Potential side effects may include:

• Anaphylaxis
• Dyspnea
• Cyanosis
• Pain, swelling, and phlebitis at the injection site
• Diaphoresis
• Dizziness
• Hypotension (rare)
• Allergic reactions after subcutaneous and intramuscular injections

Interactions with Other Medications

 K-One MM may decrease the effectiveness of oral anticoagulants.